Abbott Laboratories (LON:0Q15)
128.36
+2.52 (2.01%)
At close: Jan 6, 2026
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of 164.6 billion as of January 7, 2026. Its market cap has increased by 6.03% in one year.
Market Cap
164.60B
Enterprise Value
168.71B
Revenue
32.62B
Ranking
n/a
PE Ratio
15.89
Stock Price
128.36
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 164.60B, an increase of 25,768.59%. That is a compound annual growth rate of 10.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 163.95B | 1.29% |
| Dec 31, 2025 | 161.87B | 3.29% |
| Dec 31, 2024 | 156.71B | 4.46% |
| Dec 29, 2023 | 150.02B | -5.57% |
| Dec 30, 2022 | 158.87B | -10.87% |
| Dec 31, 2021 | 178.25B | 29.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.77B |
| HSBC Holdings | 204.35B |
| Shell | 157.82B |
| Unilever | 106.78B |
| Rio Tinto Group | 102.22B |
| Rolls-Royce Holdings | 100.20B |
| British American Tobacco p.l.c. | 91.02B |
| GSK plc | 73.48B |